As global medical device companies try to take on more of the care continuum, they might be able to turn to that little Starbucks coffee shop just around the corner. It might seem sacrilege to compare the intricacies of neuromodulation with a perfectly brewed, expertly crafted cup of joe, but here I find myself. Why? […]
The bottom line of PricewaterhouseCoopers’ Health Research Institute report on innovation in the medtech industry can be summed up as follows: “The value of a device is no longer solely in the product itself.” While clinical efficacy is a must, the true value in medtech today is a company’s ability to provide information, services, and […]
Not everyone’s buying Medtronic‘s (MDT) new do. On the heels of Medtronic’s Q1 results report, Deutsche Bank analyst Greg Poole had this to say: . . . of greater interest to us was management’s commentary on the quarterly call regarding its strategy of transforming from a device provider to a global medical technology solutions partner. While […]
When Medtronic announced its acquisition of Cardiocom earlier this week, it was a big (and loud) move in shaping the company’s “now we’re a healthcare service provider” strategy. But Cardiocom only makes $40 to $50 million in revenue, relatively small potatoes for a titan like Medtronic. What does this announcement mean, really, then? “The importance […]
